Trends in the prescription of opioids and gabapentinoids in patients with failed back surgery syndrome in Korea: a population-based study

키워드

참고문헌 (50)

1. Wu A, "Global low back pain prevalence and years lived with disability from 1990 to 2017 : estimates from the Global Burden of Disease Study 2017", Ann Transl Med, 8, pp.299~ (2020)
2. Deyo RA, "United States trends in lumbar fusion surgery for degenerative conditions", Spine(Phila Pa 1976), 30, pp.1441~1445 (2005)
3. "2020 Annual report of major surgery statistics" (2021)[URL]
4. Baber Z, "Failed back surgery syndrome : current perspectives", J Pain Res, 9, pp.979~987 (2016)
5. Waguespack A, "Etiology of long-term failures of lumbar spine surgery", Pain Med, 3, pp.18~22 (2002)
6. Parker SL, "Incidence of low back pain after lumbar discectomy for herniated disc and its effect on patient-reported outcomes", Clin Orthop Relat Res, 473, pp.1988~1999 (2015)
7. Chen YC, "Narcotic addiction in failed back surgery syndrome", Cell Transplant, 28, pp.239~247 (2019)
8. Goodman CW, "A clinical overview of offlabel use of gabapentinoid drugs", JAMA Intern Med, 179, pp.695~701 (2019)
9. Evoy KE, "Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose : an analysis of the Food and Drug Administration Adverse Events Reporting System(FAERS)", Res Social Adm Pharm, 15, pp.953~958 (2019)
10. Von Korff M, "De facto long-term opioid therapy for noncancer pain", Clin J Pain, 24, pp.521~527 (2008)
11. Pereira J, "Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing", J Pain Symptom Manage, 22, pp.672~687 (2001)
12. Swarm RA, "Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology", J Natl Compr Canc Netw, 17, pp.977~1007 (2019)
13. Petersen EA, "Persistent spinal pain syndrome : new terminology for a new era", J Pain Res, 14, pp.1627~1630 (2021)
14. Treede RD, "Chronic pain as a symptom or a disease : the IASP Classification of Chronic Pain for the International Classification of Diseases(ICD-11)", Pain, 160, pp.19~27 (2019)
15. Thomson S, "Demographic characteristics of patients with severe neuropathic pain secondary to failed back surgery syndrome", Pain Pract, 9, pp.206~215 (2009)
16. Patel R, "Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain", Pharmacol Res Perspect, 4, pp.e00205~ (2016)
17. Robertson K, "Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica : a randomized clinical trial", JAMA Neurol, 76, pp.28~34 (2019)
18. Mu A, "Pharmacologic management of chronic neuropathic pain : review of the Canadian Pain Society consensus statement", Can Fam Physician, 63, pp.844~852 (2017)
19. Johansen ME, "Gabapentinoid use in the United States 2002 through 2015", JAMA Intern Med, 178, pp.292~294 (2018)
20. Hudson TJ, "Epidemiology of regular prescribed opioid use : results from a national, population-based survey", J Pain Symptom Manage, 36, pp.280~288 (2008)
21. Sullivan MD, "Problems and concerns of patients receiving chronic opioid therapy for chronic noncancer pain", Pain, 149, pp.345~353 (2010)
22. Chaparro LE, "Opioids compared to placebo or other treatments for chronic low-back pain", Cochrane Database Syst Rev, (8), pp.CD004959~ (2013)
23. Krebs EE, "Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain : the SPACE randomized clinical trial", JAMA, 319, pp.872~882 (2018)
24. Sullivan MD, "Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans : the TROUP study", Pain, 138, pp.440~449 (2008)
25. Martin BI, "Expenditures and health status among adults with back and neck problems", JAMA, 299, pp.656~664 (2008)
26. Song IA, "Long-term opioid use and mortality in patients with chronic non-cancer pain : ten-year follow-up study in South Korea from 2010through 2019", EClinicalMedicine, 51, pp.101558~ (2022)
27. Long DM, "Clinical features of the failed-back syndrome", J Neurosurg, 69, pp.61~71 (1988)
28. Volkow ND, "Opioid abuse in chronic pain--misconceptions and mitigation strategies", N Engl J Med, 374, pp.1253~1263 (2016)
29. Kobus AM, "Correlates of higher-dose opioid medication use for low back pain in primary care", J Pain, 13, pp.1131~1138 (2012)
30. Dunn KM, "Opioid prescriptions for chronic pain and overdose : a cohort study", Ann Intern Med, 152, pp.85~92 (2010)
31. Busse JW, "Guideline for opioid therapy and chronic noncancer pain", CMAJ, 189, pp.E659~E666 (2017)
32. Häuser W, "Recommendations of the second update of the LONTS guidelines: long-term opioid therapy for chronic noncancer pain", Schmerz, 34, pp.204~244 (2020)
33. Moisset X, "Opioid use for the management of chronic non-cancer pain : French guidelines", Rev Neurol (Paris), 172, pp.337~338 (2016)
34. Schwan S, "A signal for an abuse liability for pregabalin--results from the Swedish spontaneous adverse drug reaction reporting system", Eur J Clin Pharmacol, 66, pp.947~953 (2010)
35. Peckham AM, "Prevalence of gabapentin abuse : comparison with agents with known abuse potential in a commercially insured US population", Clin Drug Investig, 37, pp.763~773 (2017)
36. Campbell LS, "Gabapentin controlled substance status", J Am Pharm Assoc (2003), 61, pp.e218~24 (2021)
37. Bao H, "The efficacy of gabapentin combined with opioids for neuropathic cancer pain : a meta-analysis", Transl Cancer Res, 10, pp.637~644 (2021)
38. Knezevic NN, "A retrospective analysis of gabapentinoid and opioids to opioid monotherapy for pain relief in patients with chronic neck and low back pain", Pain Med, 22, pp.1760~1766 (2021)
39. Peckham AM, "All-cause and drug-related medical events associated with overuse of gabapentin and", or opioid medications : a retrospective cohort analysis of a commercially insured US population, 2018, pp.41, 213~228
40. Peet ED, "Trends in the concurrent prescription of opioids and gabapentin in the US, 2006 to 2018", JAMA Intern Med, 183, pp.162~164 (2023)
41. Højsted J, "Classification and identification of opioid addiction in chronic pain patients", Eur J Pain, 14, pp.1014~1020 (2010)
42. O'Brien T, "European Pain Federation position paper on appropriate opioid use in chronic pain management", Eur J Pain, 21, pp.3~19 (2017)
43. Elkholy MAE, "Effect of spinal cord stimulation on quality of life and opioid consumption in patients with failed back surgery syndrome", Pain Pract (2023)[DOI]
44. De La Porte C, "Spinal cord stimulation in failed back surgery syndrome", Pain, 52, pp.55~61 (1993)
45. Van Buyten JP, "Efficacy of spinal cord stimulation : 10 years of experience in a pain centre in Belgium", Eur J Pain, 5, pp.299~307 (2001)
46. de la Porte C, "Lumbosacral spinal fibrosis (spinal arachnoiditis). Its diagnosis and treatment by spinal cord stimulation", Spine (Phila Pa 1976), 8, pp.593~603 (1983)
47. Ohnmeiss DD, "Prospective outcome evaluation of spinal cord stimulation in patients with intractable leg pain", Spine (Phila Pa 1976), 21, pp.1344~1350 (1996)
48. Nissen M, "Higher preimplantation opioid doses associated with longterm spinal cord stimulation failure in 211 patients with failed back surgery syndrome", Neuromodulation, 24, pp.102~111 (2021)
49. Dhruva SS, "Long-term outcomes in use of opioids, nonpharmacologic pain interventions, and total costs of spinal cord stimulators compared with conventional medical therapy for chronic pain", JAMA Neurol, 80, pp.18~29 (2023)
50. Yousef AA, "The role of adding hyaluronidase to fluoroscopically guided caudal steroid and hypertonic saline injection in patients with failed back surgery syndrome : a prospective, double-blinded, randomized study", Pain Pract, 10, pp.548~553 (2010)

관련 논문AI추천